Brief: Sareum Holdings Provides Update On SDC-1801
15/03/2023 07:52
March 15 (Reuters) - Sareum Holdings PLC SAR.L :
* UPDATE ON SDC-1801
* INITIATED AN APPLICATION TO PERFORM PHASE 1 CLINICAL
STUDIES ON
SDC-1801 IN AUSTRALIA UNDER CLINICAL TRIAL NOTIFICATION SCHEME
* DECISION ON APPROVAL BY HREC & ACCEPTANCE OF CTN BY
AUSTRALIA'S
MEDICINES REGULATOR, TGA EXPECTED IN Q2 2023
Source text for Eikon: ID:nRSO9767Sa
Further company coverage: SAR.L
((Reuters.Briefs@thomsonreuters.com;;))